DRNA NASDAQ
Dicerna Pharmaceuticals, Inc.
1W: +1.1%
1M: +0.6%
3M: +83.3%
1Y: +63.1%
3Y: +263.6%
5Y: +1153.1%
$38.22
Last traded 2021-12-27 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$193M
Revenue
+47.9% YoY
$-124M
Net Income
-7.4% YoY
$9M
Free Cash Flow
-95.7% YoY
100.0%
Gross Margin
-32.2%
Op. Margin
-27.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-95.2%
ROA-17.1%
ROIC24.4%
Valuation
P/E-25.3
P/B20.7
EV/EBITDA-9.0
Leverage
Debt/Equity0.60
Current Ratio2.46
Interest Cov.-7207.0x
Quality Scores
Piotroski F3/9
Altman Z0.52
Beneish M-1.24